Home › Trial NCT02898051
Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism
- Trial IDNCT02898051
- StatusUnknown
- PhaseN/A
- Study typeObservational
- SponsorAssistance Publique - Hôpitaux de Paris
- Enrollment370
- Start date2011-08
- ConditionsNeoplasms · Venous Thromboembolism
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.